Hemodialysis and Peritoneal Dialysis Market: Growth, Size, Share, and Trends

Report Code MD 2157
Published in Apr, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) & Region - Global Forecast to 2029

Overview

The global hemodialysis and peritoneal dialysis market, valued at US$87.2 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$92.0 billion in 2024 and an impressive US$126.2 billion by 2029. This growth is driven by the rising prevalence of chronic kidney disease (CKD), particularly due to aging populations and increasing rates of diabetes and hypertension. Technological advancements, patient preference for home dialysis, and supportive reimbursement policies are key factors boosting market demand. However, complications linked to dialysis procedures and product recalls pose challenges. The market offers significant opportunities in emerging regions like China, India, and Brazil, where healthcare spending is increasing. Key players include Fresenius Medical Care, Baxter International, and DaVita Inc., and recent developments such as acquisitions and partnerships are enhancing market capabilities. North America is expected to maintain the largest market share due to its advanced healthcare infrastructure and growing adoption of home-based dialysis.

Attractive Opportunities in the Hemodialysis and peritoneal dialysis market

NORTH AMERICA:

Market growth in North America can be attributed to rising prevalence of chronic diseases, such as diabetes, hypertension, rising patient pool with chronic kidney diseases, surge in dialysis procedures, favorable reimbursement policy, large presence of dialysis services providers

The growth of this market can be attributed to the increasing prevalence of ESRD, increasing aging population at a higher risk of renal disease, and advancements in dialysis technology.

Growing patient preference for home dialysis, rising investment in healthcare infrastructure, geographical expansion of dialysis service providers and collaboration with healthcare are likely to promote significant growth opportunity of the market

North America dominates the hemodialysis and peritoneal dialysis market. This market is projected to reach USD 57.4 billion by 2029, at a CAGR of 6.2% during the forecast period.

Asia Pacific is the fastest-growing regional market for hemodialysis and peritoneal dialysis products, with China and India emerging as major growth hotspots.

Global Hemodialysis and peritoneal dialysis market Dynamics

DRIVER: Rising prevalence of chronic kidney disease globally

The rising prevalence of chronic kidney disease (CKD) globally is expected to significantly drive the hemodialysis and peritoneal dialysis market. Chronic kidney disease is likely to affect more than 10% of the population worldwide as chronic kidney disease becomes more prevalent due to factors such as aging populations, increasing rates of diabetes and hypertension, increasing the CKD progression to end-stage renal diseases, necessitating the dialysis. Chronic kidney disease (CKD) is more prevalent among individuals aged 65 years or older. According to Centres of Disease Control and Prevention (CDC), an estimated 35.5 million people in US were diagnosed with CKD in 2023.

RESTRAINT: Complications linked with dialysis procedures

Dialysis, an essential renal replacement therapy for patients with end-stage renal disease, is associated with risks and complications. ESRD patients undergoing treatment are more susceptible to infections ranging from bloodstream infections to access site infections. Infectious and non-infectious vascular access complications are common and associated with increased morbidity, mortality, high costs, and reduced quality of life in dialysis patients. ESRD patients who choose HD require vascular access (catheters, grafts, and fistulae), and those who choose PD require a peritoneal catheter before initiation of RRT. The type of vascular access used in HD patients significantly influences patient survival due to associated complications. Compared with grafts and fistulae, catheters are associated with a substantially greater risk of sepsis, hospitalization, and mortality in HD patients. These associated risks and complications negatively affect the adoption of dialysis treatment among ESRD patients, thereby hampering the growth of the dialysis market.

 

OPPORTUNITY: High growth potential of emerging markets

Emerging markets such as China, India, Brazil, are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of diabetes, chronic kidney diseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by BMC Nephrology in 2023, in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers.Moreover, the rise in number of dialysis clinics in emerging countries can present a significant opportunity for hemodialysis and peritoneal dialysis market growth. Moreover initiatives undertaken by government to improve the access to healthcare services, including dialysis, across emerging nations through investment in healthcare infrastructure, subsidizing treatment costs are likely to enhance the market growth opportunities. Government of India has implemented Pradhan Mantri National Dialysis Programme (PMNDP) that offers free-of-cost dialysis services to Below Poverty Line (BPL) beneficiaries at district hospitals across the country. As of 31st December 2022, around 1.7 million beneficiaries availed of Haemodialysis and Peritoneal Dialysis services under PMNDP.

CHALLENGE: Product Recall

The dialysis market has witnessed several recalls in the last few years due to health hazards related to their use and regulatory non-compliance. For instanceIn 2023, Baxter Healthcare Corporation has recalled almost 280,000 bags of Dianeal peritoneal dialysis solution due to sterility concerns over potential leaks, according to the US Food and Drug Administration (FDA)In 2023, Fresenius Medical Care recalled several hemodialysis machines for potential exposure to toxic compounds such as non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) that leak from some peroxide-cured silicone tubing used as part of the hydraulics in the machine and dialysate lines.Recalls of dialysis devices place a significant financial burden on manufacturing firms due to costs to implement the recall, costs involved in product replacement, and the downturn in sales during a period of uncertainty. This, in turn, negatively affects the product scope, adoption, sales, growth prospects, and the capital structure of the manufacturing firm.

Global Hemodialysis and peritoneal dialysis market Ecosystem Analysis

The hemodialysis services to capture the largest market share of hemodialysis and peritoneal dialysis industry. Based on the hemodialysis products and services market, the hemodialysis services segment holds the largest hemodialysis and peritoneal dialysis market share owing to growing number of ESRD patients and increasing utilization of hemodialysis treatment modality. Moreover, hemodialysis services are focusing on expanding their services offerings by launching and acquiring new dialysis centers across the globe. In January 2024, Diaverum, a Sweden based renal care service provider, acquired a network of six dialysis clinics across Greece, thus enhancing its customer base across the country.

 

By End User, home care settings to grow at a significant rate from 2024-2029 of hemodialysis and peritoneal dialysis industry.

Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures.

 

 

NORTH AMERICA Region Holds the Largest Share of the Hemodialysis and peritoneal dialysis market.

North America is expected to be the largest regional market for hemodialysis and peritoneal dialysis market during the forecast period. The presence of a well-established healthcare system, rapid increase in the availability of medical reimbursement for dialysis procedures, growing adoption of home-based dialysis modality, increasing prevalence of end-stage renal diseases across the nation, and strong geographical footprint of dialysis product manufacturers and service provider focusing on collaboration with renal care institutions are likely to support the hemodialysis and peritoneal dialysis market growth across the region.

 
 

Recent Developments of Hemodialysis and peritoneal dialysis market industry

  • In July 2023, Rockwell Medical acquired the hemodialysis concentrates business from Evoqua Water Technologies, strengthening its presence in the hemodialysis market In January 2022, Nextkidney BV acquired Dialyss Pte Ltd, enhancing its technology capabilities in home hemodialysis
  • In March 2021, DaVita Inc. signed an agreement with Fresenius Medical Care AG & Co. KGaA for the expansion of the usage of NxStage Home Hemodialysis Machines

Key Market Players

KEY PLAYERS IN THE Hemodialysis and peritoneal dialysis market INCLUDE

Want to explore hidden markets that can drive new revenue in Hemodialysis and Peritoneal Dialysis Market?

Scope of the Report

Report Attribute Details
Market Revenue Size in 2024 $92.0 billion
Projected Revenue Size by 2029 $126.2 billion
Industry Growth Rate Poised to Grow at a CAGR of 6.5%
Market Driver Rising prevalence of chronic kidney disease globally
Market Opportunity High growth potential of emerging markets

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global hemodialysis and peritoneal dialysis market?
The global hemodialysis and peritoneal dialysis market boasts a total revenue value of $126.2 billion by 2029.
What is the estimated growth rate (CAGR) of the global hemodialysis and peritoneal dialysis market?
The global hemodialysis and peritoneal dialysis market has an estimated compound annual growth rate (CAGR) of 6.5% and a revenue size in the region of $92.0 billion in 2024

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Hemodialysis and Peritoneal Dialysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
36
EXECUTIVE SUMMARY
47
PREMIUM INSIGHTS
50
MARKET OVERVIEW
54
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising prevalence of chronic kidney diseases
    - Growing prevalence of diabetes and hypertension
    - Technological advancements and increased investment in R&D
    RESTRAINTS
    - Risks and complications of dialysis treatments
    - High procedural cost of dialysis
    OPPORTUNITIES
    - Increasing growth opportunities in emerging economies
    - Rising number of dialysis centers
    - Growing preference for home hemodialysis
    CHALLENGES
    - Increasing number of product recalls
    - Shortage of skilled nephrologists and lack of training programs in low-income countries
  • 5.3 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 REIMBURSEMENT ANALYSIS
    NORTH AMERICA
    EUROPE
    - Germany
    - France
    - UK
    ASIA PACIFIC
    - India
    - China
    - Japan
    - Pacific Region
    - Other Asia Pacific Countries
  • 5.5 ECOSYSTEM/MARKET MAP
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Portable hemodialysis
    COMPLEMENTARY TECHNOLOGIES
    - Biocompatible dialysis membrane
    - Connected health and remote sensors
    ADJACENT TECHNOLOGIES
    - Wearable artificial kidney
  • 5.9 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 PRICING ANALYSIS
  • 5.11 TRADE ANALYSIS
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
HEMODIALYSIS MARKET, BY PRODUCT & SERVICE
87
  • 6.1 INTRODUCTION
  • 6.2 HEMODIALYSIS SERVICES
    IN-CENTER HEMODIALYSIS SERVICES
    - Growing geriatric population and increasing government healthcare expenditure to drive segment
    HOME HEMODIALYSIS SERVICES
    - Poor reimbursement scenario and high treatment costs to limit market growth
  • 6.3 HEMODIALYSIS PRODUCTS
    HEMODIALYSIS MACHINES
    - Center-use hemodialysis machines
    - Home-use hemodialysis machines
    HEMODIALYSIS CONSUMABLES & SUPPLIES
    - Dialyzers
    - Bloodlines
    - Concentrates/Dialysates
    - Access products
    - Other hemodialysis consumables & supplies
  • 6.4 HEMODIALYSIS MARKET, BY MODALITY
    CONVENTIONAL LONG-TERM HEMODIALYSIS
    - Technological advancements and rising number of dialysis centers to drive segment
    SHORT DAILY HEMODIALYSIS
    - Improved blood pressure control and better calcium-phosphorus balance to augment segment growth
    NOCTURNAL HEMODIALYSIS
    - Lower procedure costs to aid segment growth
  • 6.5 WATER TREATMENT SYSTEMS MARKET, BY TYPE
    CENTRAL WATER DISINFECTION SYSTEMS
    - Cost effectiveness and easy maintenance to drive market
    PORTABLE WATER DISINFECTION SYSTEMS
    - User-friendly operations and improved microbiological purity to support segment growth
PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE
114
  • 7.1 INTRODUCTION
  • 7.2 PERITONEAL DIALYSIS PRODUCTS
    PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
    - High demand for concentrates to boost segment growth
    PERITONEAL DIALYSIS MACHINES
    - Rising prevalence of chronic diseases in emerging economies to boost adoption
    PERITONEAL DIALYSIS CATHETERS
    - Favorable reimbursement policies to support market growth
    PERITONEAL DIALYSIS TRANSFER SETS
    - Increasing number of patients in emerging economies to aid market growth
    OTHER PERITONEAL DIALYSIS PRODUCTS
  • 7.3 PERITONEAL DIALYSIS SERVICES
    BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
  • 7.4 PERITONEAL DIALYSIS MARKET, BY MODALITY
    CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
    - Superior clearance of high-molecular-weight substances to drive market
    AUTOMATED PERITONEAL DIALYSIS
    - Risk of rapid decline in residual renal functions to limit adoption
HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION
124
  • 8.1 INTRODUCTION
  • 8.2 END-STAGE RENAL DISEASE
    RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
  • 8.3 ACUTE KIDNEY INJURY
    INCREASE IN NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH
  • 8.4 OTHER DISEASES
HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER
128
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
  • 9.3 INDEPENDENT DIALYSIS CENTERS
    INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH
  • 9.4 HOME CARE SETTINGS
    LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
  • 9.5 OTHER END USERS
HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION
134
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to account for largest market share during study period
    CANADA
    - Shortage of dialysis facilities and increased treatment cost to limit market
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising number of end-stage renal disease patients to boost market growth
    UK
    - Increased number of new dialysis centers and technological advancements to support market growth
    FRANCE
    - High cost of dialysis treatment and variation in reimbursement policies to limit market growth
    ITALY
    - Increasing research activities and growing patient population with acute renal failure to augment market growth
    SPAIN
    - Favorable reimbursement scenario to boost market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - High prevalence of end-stage renal disease and large geriatric population to support market growth
    CHINA
    - Increasing prevalence of diabetes and hypertension to drive market
    INDIA
    - Favorable government initiatives and high prevalence of kidney disease to fuel market growth
    AUSTRALIA
    - Increasing government initiatives about renal care to support market growth
    SOUTH KOREA
    - Growing geriatric population with chronic kidney disease to propel market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Brazil to account for largest share of Latin American market during forecast period
    MEXICO
    - Increasing patient population and growing middle class population to boost market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
    GCC COUNTRIES
    - Higher disposable income and increased government healthcare expenditure to propel market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
222
  • 11.1 INTRODUCTION
  • 11.2 KEY STRATEGIES/RIGHT-TO-WIN
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    PERVASIVE PLAYERS
    EMERGING LEADERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS
    - Regional footprint
    - Product & service footprint
    - Disease indication footprint
    - End user footprint
  • 11.6 COMPETITIVE EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: START-UPS/SMES
  • 11.7 VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
241
  • 12.1 KEY PLAYERS
    FRESENIUS MEDICAL CARE AG
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BAXTER
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    DAVITA INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    NIKKISO CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ASAHI KASEI CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    TERUMO CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    TORAY MEDICAL CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    NIPRO CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    DIAVERUM AB
    - Business overview
    - Products/Services/Solutions offered
    DIALIFE SA
    - Business overview
    - Products/Services/Solutions offered
    ISOPURE CORP.
    - Business overview
    - Products/Services/Solutions offered
    ROCKWELL MEDICAL, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    JMS CO. LTD.
    ALLMED MEDICAL PRODUCTS CO., LTD.
    ATLANTIC BIOMEDICAL
    ANGIODYNAMICS
    AMECATH
    COOK
    MEDICAL COMPONENTS INC.
    POLYMEDICURE
    XYLEM
    OUTSET MEDICAL, INC.
APPENDIX
297
  • 13.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.2 CUSTOMIZATION OPTIONS
  • 13.3 RELATED REPORTS
  • 13.4 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH)
  • TABLE 3 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2012 VS. 2050
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 MEDICAL REIMBURSEMENT CODES FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES
  • TABLE 10 AVERAGE PRICE OF HEMODIALYSIS AND PERITONEAL DIALYSIS SYSTEMS AND CONSUMABLES IN 2022, BY COUNTRY (USD)
  • TABLE 11 AVERAGE SELLING PRICE OF HEMODIALYSIS & PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER (USD)
  • TABLE 12 IMPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, 2024–2025
  • TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
  • TABLE 17 BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
  • TABLE 18 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD BILLION)
  • TABLE 19 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 20 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 21 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 22 HOME HEMODIALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 23 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 24 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 25 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 26 HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 27 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 28 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 29 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 30 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 31 DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 32 DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION)
  • TABLE 33 SYNTHETIC DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 34 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 35 DIALYZERS MARKET, BY FLUX, 2022–2029 (USD BILLION)
  • TABLE 36 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 37 LOW-FLUX DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 38 BLOODLINES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 39 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 40 CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 41 ALKALINE CONCENTRATES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 42 ACIDIC CONCENTRATES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 43 ACCESS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 44 ACCESS PRODUCTS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 45 AV FISTULA NEEDLES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 46 AV GRAFTS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 47 CENTRAL VENOUS CATHETERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 48 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 49 HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 50 HEMODIALYSIS MARKET FOR CONVENTIONAL LONG-TERM HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 51 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 52 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 53 WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 54 WATER TREATMENT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 WATER TREATMENT SYSTEMS MARKET FOR CENTRAL WATER DISINFECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 WATER TREATMENT SYSTEMS MARKET FOR PORTABLE WATER DISINFECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD BILLION)
  • TABLE 58 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 59 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 60 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 61 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 62 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 63 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 64 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 65 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 66 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 67 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 68 PERITONEAL DIALYSIS MARKET FOR AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 69 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION, 2022–2029 (USD BILLION)
  • TABLE 70 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 71 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 72 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 73 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD BILLION)
  • TABLE 74 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 75 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 76 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 77 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 78 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 79 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 80 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 81 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 82 NORTH AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 83 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION)
  • TABLE 84 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2022–2029 (USD BILLION)
  • TABLE 85 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 86 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 87 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 88 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 89 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 91 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 92 US: MACROECONOMIC INDICATORS
  • TABLE 93 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 94 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 95 US: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 96 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 97 US: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 98 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 99 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 100 US: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 101 CANADA: MACROECONOMIC INDICATORS
  • TABLE 102 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 103 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 104 CANADA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 105 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 106 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 107 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 109 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 110 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 111 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 112 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 113 EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 114 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 115 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 116 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 118 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 119 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 120 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 121 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 122 GERMANY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 123 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 124 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 125 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 127 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 128 UK: MACROECONOMIC INDICATORS
  • TABLE 129 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 130 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 131 UK: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 132 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 133 UK: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 134 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 136 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 137 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 138 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 139 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 140 FRANCE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 141 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 142 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 143 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 145 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 146 ITALY: MACROECONOMIC INDICATORS
  • TABLE 147 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 148 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 149 ITALY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 150 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 151 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 152 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 154 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 155 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 156 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 157 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 158 SPAIN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 159 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 160 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 161 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 163 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 164 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 165 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 166 REST OF EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 167 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 168 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 169 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 170 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 171 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 172 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 173 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 174 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 175 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 176 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 177 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 179 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 180 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 181 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 182 JAPAN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 183 JAPAN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 184 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 185 JAPAN: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 186 JAPAN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 188 JAPAN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 189 CHINA: MACROECONOMIC INDICATORS
  • TABLE 190 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 191 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 192 CHINA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 193 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 194 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 195 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 197 CHINA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 198 INDIA: MACROECONOMIC INDICATORS
  • TABLE 199 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 200 INDIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 201 INDIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 202 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 203 INDIA: HEMODIALYSIS MARKET, BY MODALITY 2022–2029 (USD BILLION)
  • TABLE 204 INDIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 INDIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 207 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 208 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 209 AUSTRALIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 210 AUSTRALIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 211 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 212 AUSTRALIA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 213 AUSTRALIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 215 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 216 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 217 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 218 SOUTH KOREA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 219 SOUTH KOREA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 220 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 221 SOUTH KOREA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 222 SOUTH KOREA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 224 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 225 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 226 REST OF ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 227 REST OF ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 228 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION)
  • TABLE 229 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 230 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 231 REST OF ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 233 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 234 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 235 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 236 LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 237 LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 238 LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION)
  • TABLE 239 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 240 LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 241 LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 243 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 244 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 245 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 246 BRAZIL: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 247 BRAZIL: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 248 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 249 BRAZIL: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 250 BRAZIL: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 252 BRAZIL: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 253 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 254 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 255 MEXICO: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 256 MEXICO: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 257 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 258 MEXICO: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 259 MEXICO: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 261 MEXICO: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 262 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 263 REST OF LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 264 REST OF LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 265 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 266 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 267 REST OF LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 269 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 276 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 278 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 279 GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 280 GCC COUNTRIES: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 281 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 282 GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 283 GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 284 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION)
  • TABLE 294 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
  • TABLE 295 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OVERALL FOOTPRINT
  • TABLE 296 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONAL FOOTPRINT
  • TABLE 297 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT & SERVICE FOOTPRINT
  • TABLE 298 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DISEASE INDICATION FOOTPRINT
  • TABLE 299 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: END USER FOOTPRINT
  • TABLE 300 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 301 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • TABLE 302 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARISON, BY PRODUCT
  • TABLE 303 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024
  • TABLE 304 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 305 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
  • TABLE 306 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
  • TABLE 307 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
  • TABLE 308 FRESENIUS MEDICAL CARE AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 309 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES
  • TABLE 310 FRESENIUS MEDICAL CARE AG: DEALS
  • TABLE 311 BAXTER: COMPANY OVERVIEW
  • TABLE 312 BAXTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 313 BAXTER: DEALS
  • TABLE 314 DAVITA INC.: COMPANY OVERVIEW
  • TABLE 315 DAVITA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 316 DAVITA INC.: DEALS
  • TABLE 317 DAVITA INC.: EXPANSIONS
  • TABLE 318 NIKKISO CO., LTD.: COMPANY OVERVIEW
  • TABLE 319 NIKKISO CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 320 NIKKISO CO., LTD.: DEALS
  • TABLE 321 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 322 B. BRAUN SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 323 B. BRAUN SE: PRODUCT LAUNCHES
  • TABLE 324 B. BRAUN SE: EXPANSIONS
  • TABLE 325 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 327 MEDTRONIC: DEALS
  • TABLE 328 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 329 ASAHI KASEI CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 330 ASAHI KASEI CORPORATION: DEALS
  • TABLE 331 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 332 TERUMO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 333 TERUMO CORPORATION: DEALS
  • TABLE 334 TERUMO CORPORATION: OTHER DEVELOPMENTS
  • TABLE 335 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 336 TORAY MEDICAL CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 337 NIPRO CORPORATION: COMPANY OVERVIEW
  • TABLE 338 NIPRO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 339 NIPRO CORPORATION: DEALS
  • TABLE 340 DIAVERUM AB: COMPANY OVERVIEW
  • TABLE 341 DIAVERUM AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 342 DIALIFE SA: COMPANY OVERVIEW
  • TABLE 343 DIALIFE SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 344 ISOPURE CORP.: COMPANY OVERVIEW
  • TABLE 345 ISOPURE CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 346 ROCKWELL MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 347 ROCKWELL MEDICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 348 ROCKWELL MEDICAL, INC.: DEALS
  • TABLE 349 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 350 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 351 BECTON, DICKINSON AND COMPANY: EXPANSIONS
  • TABLE 352 JMS CO. LTD.: COMPANY OVERVIEW
  • TABLE 353 ALLMED MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW
  • TABLE 354 ATLANTIC BIOMEDICAL: COMPANY OVERVIEW
  • TABLE 355 ANGIODYNAMICS: COMPANY OVERVIEW
  • TABLE 356 AMECATH: COMPANY OVERVIEW
  • TABLE 357 COOK: COMPANY OVERVIEW
  • TABLE 358 MEDICAL COMPONENTS INC.: COMPANY OVERVIEW
  • TABLE 359 POLYMEDICURE: COMPANY OVERVIEW
  • TABLE 360 XYLEM: COMPANY OVERVIEW
  • TABLE 361 OUTSET MEDICAL, INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SEGMENTS COVERED
  • FIGURE 2 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONS COVERED
  • FIGURE 3 RESEARCH DESIGN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 4 INDICATIVE LIST OF SECONDARY SOURCES
  • FIGURE 5 LIST OF KEY PRIMARY SOURCES
  • FIGURE 6 KEY INDUSTRY INSIGHTS
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 ESTIMATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES, BY COUNTRY/REGION
  • FIGURE 9 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT UTILIZATION METHODOLOGY
  • FIGURE 10 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES MARKET, BY REVENUE MAPPING METHODOLOGY
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
  • FIGURE 13 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
  • FIGURE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
  • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
  • FIGURE 16 RISING PREVALENCE OF END-STAGE RENAL DISEASE AND GROWING AWARENESS ABOUT DIALYSIS TREATMENT TO DRIVE MARKET
  • FIGURE 17 HEMODIALYSIS CONSUMABLES & SUPPLIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 18 CONVENTIONAL LONG-TERM HEMODIALYSIS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
  • FIGURE 19 JAPAN AND PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 CANADA: NUMBER OF TOTAL INCIDENTS OF END-STAGE RENAL DISEASE PATIENTS, BY AGE GROUP (2022)
  • FIGURE 23 US: REPORTED CAUSES OF END-STAGE RENAL DISEASES, 2023
  • FIGURE 24 INCIDENCE OF TREATED END-STAGE RENAL DISEASE PATIENTS, 2021
  • FIGURE 25 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2013–MARCH 2024)
  • FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS MACHINE PATENTS (JANUARY 2013–MARCH 2024)
  • FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PERITONEAL DIALYSIS CYCLER PATENTS (JANUARY 2013–MARCH 2024)
  • FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS DIALYSATE PATENTS (JANUARY 2013–MARCH 2024)
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
  • FIGURE 32 KEY BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS
  • FIGURE 33 INVESTMENT AND FUNDING SCENARIO FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET PLAYERS
  • FIGURE 34 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: STRATEGIES ADOPTED
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS (2019–2023)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCT
  • FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2022)
  • FIGURE 44 BAXTER: COMPANY SNAPSHOT (2023)
  • FIGURE 45 DAVITA INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2022)
  • FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2022)
  • FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 49 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 51 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT (2022)
  • FIGURE 52 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 53 ROCKWELL MEDICAL, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 54 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), American Society Nephrology (ASN), American Association of Kidney Patients (AAKP), European Renal Association (ERA) were referred to identify and collect information for the global hemodialysis and peritoneal dialysis market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the hemodialysis and peritoneal dialysis market. The primary sources from the demand side include hospitals, outpatient dialysis centers, home care setting among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Hemodialysis and Peritoneal Dialysis Market Size, and Share

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global hemodialysis and peritoneal dialysis market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 85–90% of the market share at the global level). Also, the global hemodialysis and peritoneal dialysis market was split into various segments and sub-segments based on:

  • list of major players operating in the hemodialysis and peritoneal dialysis products and services market at the regional and/or country level
  • Product mapping of various hemodialysis and Peritoneal dialysis manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from dialysis (or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 65-70% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global hemodialysis and peritoneal dialysis market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation: Hemodialysis And Peritoneal Dialysis Market Based On Revenue Mapping Methodology

Hemodialysis and Peritoneal Dialysis Market Size, and Share

Data Triangulation

After arriving at the overall size of the global Hemodialysis and peritoneal dialysis market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Dialysis refers to a medical procedure essential individual suffering from chronic kidney diseases or impaired kidney function. It involves the removal of waste products and excess fluids from the blood, a function the kidneys normally perform. Dialysis can be of two main types: hemodialysis, where blood is filtered through a machine acting as an artificial kidney, and peritoneal dialysis, which uses the lining of the abdomen as a natural filter. By balancing electrolytes and fluid levels in the body.

Key Market Stakeholders

  • Hemodialysis and Peritoneal Dialysis Product Manufacturers
  • Hemodialysis and Peritoneal Dialysis Services Providers
  • Distributors, Channel Partners, and Third-party Suppliers
  • Hospitals, Independent Dialysis Centers, skilled Nursing Facilities
  • Nephrologist
  • Dialysis Nurses
  • R&D Companies
  • Business Research and Consulting Service Providers

Report Objectives

  • To define, describe, and forecast the global hemodialysis and peritoneal dialysis market on the basis of hemodialysis and peritoneal dialysis product and Services, disease indication, end user and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global hemodialysis and peritoneal dialysis market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global hemodialysis and peritoneal dialysis market report.

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5 OEMs)

Geographic Analysis

  • Further breakdown of the Rest of Europe hemodialysis and peritoneal dialysis market into Belgium, Austria, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among other
  • Further breakdown of the Rest of Asia Pacific hemodialysis and peritoneal dialysis market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
  • Further breakdown of the Rest of Latin America hemodialysis and peritoneal dialysis market into Argentina, and Colombia, among other countries.

Previous Versions of this Report

Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Tube, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (Conventional, CAPD, Nocturnal), User (Hospital, Home Care, ASCs) - Global Forecasts to 2026

Report Code MD 2157
Published in Aug, 2021, By MarketsandMarkets™

Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User (Hospital, Independent Dialysis Center, Home Dialysis) - Global Forecasts to 2024

Report Code MD 2157
Published in Jul, 2019, By MarketsandMarkets™

Hemodialysis and Peritoneal Dialysis Market Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) - Global Forecast to 2021

Report Code MD 2157
Published in Feb, 2017, By MarketsandMarkets™

Hemodialysis & Peritoneal Dialysis Market Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, Transfer Sets, Water Treatment Systems, & Services), Modality (Nocturnal, APD, & CAPD), End-users (In-center & Home) - Global Forecast to 2020

Report Code MD 2157
Published in Nov, 2015, By MarketsandMarkets™

Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018

Report Code MD 2157
Published in Nov, 2013, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Hemodialysis and Peritoneal Dialysis Market

Alejandro

Jul, 2020

I would like to know opportunities for growth and adopción of peritoneal dialysis in Mexico.

Aaron

Mar, 2022

Looking forward to gain more insights on the global Hemodialysis Market.

Jose

Mar, 2022

Can you enlighten us on the end users in Hemodialysis Market?.

DMCA.com Protection Status